stopping and restarting glp-1 Drugs May Raise Heart Risk How to Restart GLP-1 Medications

Le Sage et al, 2016

Notes Text in parentheses is additional optional information which can be included on the label at the applicant's discretion

Additionally, Semaglutide has been approved for weight management in individuals with obesity or overweight conditions, affirming its role as a valuable tool in managing weight effectively

Women with type 2 diabetes have been found to have higher risks of infertility and miscarriage, as well as lower chances of viable pregnancy and childbirth, compared with non-diabetic women, and not all these differences are explained by obesity or PCOS

IV drip therapy is a clinical treatment that should only be administered by trained practitioners following a health assessment

Berberine takes around 3 months to take effect